UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels

Pain (Amsterdam), 2005-09, Vol.117 (1), p.88-96

2005

Volltextzugriff (PDF)

Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States

The Journal of neuroscience, 1999-09, Vol.19 (17), p.7670-7678

1999

Volltextzugriff (PDF)

Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation

Scientific reports, 2019-03, Vol.9 (1), p.5310-9, Article 5310

2019

Volltextzugriff (PDF)

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (20), p.8520-8525

2007

Volltextzugriff (PDF)

Painful purinergic receptors

The Journal of pharmacology and experimental therapeutics, 2008-02, Vol.324 (2), p.409-415

2008

Volltextzugriff (PDF)

A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat

The Journal of pharmacology and experimental therapeutics, 2006-12, Vol.319 (3), p.1376

2006

Volltextzugriff (PDF)

Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis

European journal of pharmacology, 2009-06, Vol.613 (1), p.39-45

2009

Volltextzugriff (PDF)

Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

British journal of pharmacology, 2011-01, Vol.162 (2), p.428-440

2011

Volltextzugriff (PDF)

Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery

Journal of dermatological science, 2018-10, Vol.92 (1), p.45-53

2018

Volltextzugriff (PDF)

Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris

JCI insight, 2021-10, Vol.6 (20)

2021

Volltextzugriff (PDF)

Spinal Nerve Ligation in Mouse Upregulates TRPV1 Heat Function in Injured IB4-Positive Nociceptors

The journal of pain, 2010-06, Vol.11 (6), p.588-599

2010

Volltextzugriff (PDF)

Characterization of psoriasiform dermatitis induced by systemic injection of interleukin‐23 minicircles in mice

Journal of dermatology, 2019-06, Vol.46 (6), p.482-497

2019

Volltextzugriff (PDF)

A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats

The Journal of pharmacology and experimental therapeutics, 2005-07, Vol.314 (1), p.410-421

2005

Volltextzugriff (PDF)

A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

Proceedings of the National Academy of Sciences - PNAS, 2002-12, Vol.99 (26), p.17179-17184

2002

Volltextzugriff (PDF)

Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain

The Journal of neuroscience, 1999-12, Vol.19 (24), p.10886-10897

1999

Volltextzugriff (PDF)

Comparison of mechanical allodynia and the affective component of inflammatory pain in rats

Neuropharmacology, 2010-02, Vol.58 (2), p.537-543

2010

Volltextzugriff (PDF)

Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

Pain (Amsterdam), 2002-09, Vol.99 (1-2), p.11-19

2002

Volltextzugriff (PDF)

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging

The Journal of pharmacology and experimental therapeutics, 2009-01, Vol.328 (1), p.141

2009

Volltextzugriff (PDF)

Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model

Pain (Amsterdam), 2004-07, Vol.110 (1), p.56-63

2004

Volltextzugriff (PDF)

Pharmacological modulation of brain activity in a preclinical model of osteoarthritis

NeuroImage (Orlando, Fla.), 2013-01, Vol.64, p.341-355

2013

Volltextzugriff (PDF)

Additive Antinociceptive Effects of the Selective Nav1.8 Blocker A-803467 and Selective TRPV1 Antagonists in Rat Inflammatory and Neuropathic Pain Models

The journal of pain, 2009-03, Vol.10 (3), p.306-315

2009

Volltextzugriff (PDF)

A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid

The Journal of pharmacology and experimental therapeutics, 2005-07, Vol.314 (1), p.400-409

2005

Volltextzugriff (PDF)

Transmission of Chronic Nociception by Spinal Neurons Expressing the Substance P Receptor

Science (American Association for the Advancement of Science), 1999-11, Vol.286 (5444), p.1558-1561

1999

Volltextzugriff (PDF)

Animal models of acute and chronic inflammatory and nociceptive pain

Methods in molecular biology (Clifton, N.J.), 2010-01, Vol.617, p.41

2010

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(190)
Buchkapitel
(1)

Sprache

Englisch
(191)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels

Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States

Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Painful purinergic receptors

A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat

Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis

Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery

Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris

Spinal Nerve Ligation in Mouse Upregulates TRPV1 Heat Function in Injured IB4-Positive Nociceptors

Characterization of psoriasiform dermatitis induced by systemic injection of interleukin‐23 minicircles in mice

A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats

A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia

Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain

Comparison of mechanical allodynia and the affective component of inflammatory pain in rats

Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging

Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model

Pharmacological modulation of brain activity in a preclinical model of osteoarthritis

Additive Antinociceptive Effects of the Selective Nav1.8 Blocker A-803467 and Selective TRPV1 Antagonists in Rat Inflammatory and Neuropathic Pain Models

A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid

Transmission of Chronic Nociception by Spinal Neurons Expressing the Substance P Receptor

Animal models of acute and chronic inflammatory and nociceptive pain

Suchergebnisse filtern